Authors:
STUCKLESS JS
MARSHALL BD
VANIMAN DT
DUDLEY WW
PETERMAN ZE
WHELAN JF
TAYLOR EM
FORESTER RM
OLEARY DW
Citation: Js. Stuckless et al., COMMENTS ON OVERVIEW OF CALCITE OPAL DEPOSITS AT OR NEAR THE PROPOSEDHIGH-LEVEL NUCLEAR WASTE SITE, YUCCA MOUNTAIN, NEVADA, USA PEDOGENIC,HYPOGENE, OR BOTH/, Environmental geology, 34(1), 1998, pp. 70-78
Citation: Ks. Kee et al., RISPERIDONE VERSUS HALOPERIDOL FOR PERCEPTION OF EMOTION IN TREATMENT-RESISTANT SCHIZOPHRENIA - PRELIMINARY FINDINGS, Schizophrenia research, 31(2-3), 1998, pp. 159-165
Authors:
KERN RS
GREEN MF
MARSHALL BD
WIRSHING WC
WIRSHING D
MCGURK S
MARDER SR
MINTZ J
Citation: Rs. Kern et al., RISPERIDONE VS. HALOPERIDOL ON REACTION-TIME, MANUAL DEXTERITY, AND MOTOR LEARNING IN TREATMENT-RESISTANT SCHIZOPHRENIA-PATIENTS, Biological psychiatry, 44(8), 1998, pp. 726-732
Citation: Rs. Kern et al., EFFECTS OF RISPERIDONE ON POLYDIPSIA IN CHRONIC-SCHIZOPHRENIA PATIENTS, Journal of clinical psychopharmacology, 17(5), 1997, pp. 432-435
Authors:
GREEN MF
MARSHALL BD
WIRSHING WC
AMES D
MARDER SR
MCGURK S
KERN RS
MINTZ J
Citation: Mf. Green et al., DOES RISPERIDONE IMPROVE VERBAL WORKING-MEMORY IN TREATMENT-RESISTANTSCHIZOPHRENIA, The American journal of psychiatry, 154(6), 1997, pp. 799-804
Authors:
WIRSHING WC
AMES D
MARDER SR
MARSHALL BD
GREEN MF
MCGURK S
Citation: Wc. Wirshing et al., RISPERIDONE VS HALOPERIDOL IN TREATMENT-RESISTANT SCHIZOPHRENIA - PRELIMINARY-RESULTS, Schizophrenia research, 18(2-3), 1996, pp. 5-5
Authors:
MCGURK SR
GREEN MF
WIRSHING WC
AMES D
MARSHALL BD
MARDER SR
Citation: Sr. Mcgurk et al., THE EFFECTS OF RISPERIDONE VS HALOPERIDOL ON SPATIAL WORKING-MEMORY IN TREATMENT-RESISTANT SCHIZOPHRENIA, Biological psychiatry, 39(7), 1996, pp. 245-245
Authors:
ARAVAGIRI M
MARDER SR
VANPUTTEN T
MARSHALL BD
Citation: M. Aravagiri et al., SIMULTANEOUS DETERMINATION OF PLASMA HALOPERIDOL AND ITS METABOLITE REDUCED HALOPERIDOL BY LIQUID-CHROMATOGRAPHY WITH ELECTROCHEMICAL DETECTION - PLASMA-LEVELS IN SCHIZOPHRENIC-PATIENTS TREATED WITH ORAL OR INTRAMUSCULAR DEPOT HALOPERIDOL, Journal of chromatography B. Biomedical applications, 656(2), 1994, pp. 373-381
Authors:
MIDHA KK
HUBBARD JW
MARDER SR
MARSHALL BD
VANPUTTEN T
Citation: Kk. Midha et al., IMPACT OF CLINICAL PHARMACOKINETICS ON NEUROLEPTIC THERAPY IN PATIENTS WITH SCHIZOPHRENIA, Journal of psychiatry & neuroscience, 19(4), 1994, pp. 254-264
Authors:
LIBERMAN RP
VANPUTTEN T
MARSHALL BD
MINTZ J
BOWEN L
KUEHNEL TG
ARAVAGIRI M
MARDER SR
Citation: Rp. Liberman et al., OPTIMAL DRUG AND BEHAVIOR-THERAPY FOR TREATMENT-REFRACTORY SCHIZOPHRENIC-PATIENTS, The American journal of psychiatry, 151(5), 1994, pp. 756-759
Authors:
VANPUTTEN T
MARSHALL BD
LIBERMAN R
MINTZ J
KUEHNEL TG
BOWEN L
ARAVAGIRI M
MARDER SR
Citation: T. Vanputten et al., SYSTEMATIC DOSAGE REDUCTION IN TREATMENT-RESISTANT SCHIZOPHRENIC-PATIENTS, Psychopharmacology bulletin, 29(2), 1993, pp. 315-320
Authors:
GREEN MF
MINTZ J
BOWEN L
MARSHALL BD
KUEHNEL TG
HAYDEN JL
LIBERMAN RP
Citation: Mf. Green et al., PREDICTION OF RESPONSE TO HALOPERIDOL DOSE REDUCTION BY SPAN OF APPREHENSION MEASURES FOR TREATMENT-REFRACTORY SCHIZOPHRENIC-PATIENTS, The American journal of psychiatry, 150(9), 1993, pp. 1415-1416